Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: Int J Gynecol Cancer. 2016 Jun;26(5):933–938. doi: 10.1097/IGC.0000000000000681

Table 1. Clinicopathologic features of study population.

Grade 3 Endometrioid EC
N 72
Age (median, range) 64.6 (44.3-90.7)
BMI (median, range) 31.7 (18.7-58.2)
Stage
 I/II 47 (65.3%)
 III/IV 24 (33.3%)
 Unstaged 1 (1.3%)
Deep myometrial invasion (≥50%) 33 (45.8%)
Presence of LVSI 49 (67.1%)
Adjuvant therapy (any) 41 (56.9%)

EC: endometrial cancer; BMI: body mass index; LVSI: lymphovascular space invasion.